269 related articles for article (PubMed ID: 24576870)
1. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
Mazzocchio R; Caleo M
Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
[TBL] [Abstract][Full Text] [Related]
2. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
3. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A, brain and pain.
Matak I; Lacković Z
Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
[TBL] [Abstract][Full Text] [Related]
6. Direct central nervous system effects of botulinum neurotoxin.
Caleo M; Restani L
Toxicon; 2018 Jun; 147():68-72. PubMed ID: 29111119
[TBL] [Abstract][Full Text] [Related]
7. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
8. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?
Caleo M; Antonucci F; Restani L; Mazzocchio R
J Neurochem; 2009 Apr; 109(1):15-24. PubMed ID: 19154335
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of therapy effects by botulinum neurotoxin].
Alajbegović A; Alajbegović S; Resić H
Med Arh; 2008; 62(1):53-5. PubMed ID: 18543757
[TBL] [Abstract][Full Text] [Related]
10. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A.
Shimizu T; Shibata M; Toriumi H; Iwashita T; Funakubo M; Sato H; Kuroi T; Ebine T; Koizumi K; Suzuki N
Neurobiol Dis; 2012 Dec; 48(3):367-78. PubMed ID: 22820141
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
12. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
14. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
Pickett A
BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of botulinum neurotoxin: Unexpected consequences.
Hallett M
Toxicon; 2018 Jun; 147():73-76. PubMed ID: 28803760
[TBL] [Abstract][Full Text] [Related]
16. The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord.
Mika J; Rojewska E; Makuch W; Korostynski M; Luvisetto S; Marinelli S; Pavone F; Przewlocka B
Neuroscience; 2011 Feb; 175():358-66. PubMed ID: 21111791
[TBL] [Abstract][Full Text] [Related]
17. Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement.
Šoštarić P; Matić M; Nemanić D; Lučev Vasić Ž; Cifrek M; Pirazzini M; Matak I
Eur J Pharmacol; 2024 Jan; 962():176242. PubMed ID: 38048980
[TBL] [Abstract][Full Text] [Related]
18. The structure and mode of action of different botulinum toxins.
Dolly JO; Aoki KR
Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice.
Vacca V; Marinelli S; Eleuteri C; Luvisetto S; Pavone F
Brain Behav Immun; 2012 Mar; 26(3):489-99. PubMed ID: 22281280
[TBL] [Abstract][Full Text] [Related]
20. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.
Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B
Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
